Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Is Dapagliflozin Cost-effective for Treating Heart Failure?
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Slomski A
- Source:
JAMA [JAMA] 2021 Aug 03; Vol. 326 (5), pp. 378.
- Publication Type:
News
- Language:
English
- Additional Information
- Source:
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
- Publication Information:
Original Publication: Chicago : American Medical Association, 1960-
- Subject Terms:
- Accession Number:
0 (Benzhydryl Compounds)
0 (Glucosides)
0 (Sodium-Glucose Transporter 2 Inhibitors)
1ULL0QJ8UC (dapagliflozin)
- Publication Date:
Date Created: 20210803 Date Completed: 20210811 Latest Revision: 20210811
- Publication Date:
20221213
- Accession Number:
10.1001/jama.2021.12116
- Accession Number:
34342627
No Comments.